The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Burden of allergic respiratory disease: a systematic review
Open accessAbstract
This meta-analysis compared the health-related quality of life (HRQL) of patients with allergic rhinitis (AR) and/or allergic asthma (AA) caused by perennial house dust mite (HDM) versus AR and/or AA caused by seasonal pollen allergy. Following a systematic search, the identified studies used the disease-specific rhinitis quality of life questionnaire or generic instruments (SF-36 and SF-12). Summary estimates obtained by meta-analysis showed that HRQL in patients with perennial HDM allergy was significantly worse than that of patients with seasonal pollen allergy, when measured by both disease-specific and generic HRQL instruments, and was reflected by an impact on both physical and mental health. A systematic review of cost data on AR and AA in selected European countries demonstrated that the majority of the economic burden was indirectly caused by high levels of absenteeism and presenteeism; there was little or no evidence of increasing or decreasing cost trends. Increased awareness of the detrimental effects of AR and/or AA on patients' HRQL and its considerable cost burden might encourage early diagnosis and treatment, in order to minimize the disease burden and ensure beneficial and cost-effective outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![Fig. 7 Range of EQ-5D utility index scores for selected chronic conditions. Green and red circles represent the upper and lower values, respectively. Values were obtained from published studies in populations with cancer [82], psoriasis [82], cardiovascular diseases [82], visual disorders [82], type-2 diabetes mellitus [82], end stage renal disease [82], epilepsy [83], AR/HDM or AR and AA [23, 84], migraine [84] or chronic migraine [85], liver disease [82], and active psychoses [84, 86]. Lower EQ-5D values indicate lower HRQL](https://figures.cochat.ai/paper-figures/c72041d02a9046e39bdb19dc1396f0c8/burden-of-allergic-respiratory-disease-a-systematic-review-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Two systematic reviews have evaluated the effect of AR on QOL, with both concluding that AR patients suffer from significantly decreased general and disease-specific QOL due to the impact of physical and mental health. Furthermore, both studies demonstrated that treatment of AR leads to improvement in QOL667,668”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [667]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An important aspect of QOL is the calculation of”
From Position Paper on Nasal Obstruction: Evaluation and Treatment (2018) · cites this paper as [116]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The high costs of AR are well known [95,116], with indirect costs being higher and doubling or tripling direct costs.”
From Position Paper on Nasal Obstruction: Evaluation and Treatment (2018) · cites this paper as [116]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In this sense, respiratory diseases resemble other chronic diseases such as diabetes, kidney failure, and chronic liver disease [116].”
From Position Paper on Nasal Obstruction: Evaluation and Treatment (2018) · cites this paper as [116]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Data from this study suggested that patients with mild AR have less impact on the health economy, with costs averaging about 25% of the costs for those with moderate to severe disease.667,766”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [667]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
Bousquet, J., Khaltaev, N., Cruz, A. A., Denburg, J., Fokkens, W. J., Togias, A., Zuberbier, T., Baena‐Cagnani, C. E., Canonica, G. W., Van Weel, C., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01620.x · Cited by 4,729
McHorney, C. A., Ware, J. E., Rachel Lu, J. F., & Sherbourne, C. D. (1994) · Medical Care · doi:10.1097/00005650-199401000-00004 · Cited by 4,458
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
Prevalence and rate of diagnosis of allergic rhinitis in Europe
Bauchau, V., & Durham, S. R. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00013904 · Cited by 1,022 · cited 1×
“Background In Europe, approximately 23 % of the population is affected by allergic rhinitis (AR) [1].”
BackgroundDevelopment and testing of a new measure of health status for clinical trials in rhinoconjunctivitis
JUNIPER, E. F., & GUYATT, G. H. (1991) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1991.tb00807.x · Cited by 811
Neyeloff, J. L., Fuchs, S. C., & Moreira, L. B. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-52 · Cited by 727
Preference-Based EQ-5D Index Scores for Chronic Conditions in the United States
Sullivan, P. W., & Ghushchyan, V. (2006) · Medical Decision Making · doi:10.1177/0272989x06290495 · Cited by 705
Durham, S. R., Yang, W. H., Pedersen, M. R., Johansen, N., & Rak, S. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.12.1358 · Cited by 479
A survey of the burden of allergic rhinitis in Europe
Canonica, G. W., Bousquet, J., Mullol, J., Scadding, G. K., & Virchow, J. C. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01549.x · Cited by 454
Research works printed but not linked: 1
- Mosbech H. A phase II–III trial assessing the efficacy and safety of three doses of the ALK house dust mite tablet in house dust mite-allergic subjects 81 centres in DE, DK, ES, FR, GB, IT, PL, SE. Copenhagen: National University Hospital; 2009. p. 199.
Cited by
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
Akdis (2020) · doi:10.1111/pai.13189 · Cited by 320
The burden of allergic rhinitis and allergic rhinoconjunctivitis on adolescents
Blaiss, M. S., Hammerby, E., Robinson, S., Kennedy-Martin, T., & Buchs, S. (2018) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2018.03.028 · Cited by 213
Self-citationBiological weed control to relieve millions from Ambrosia allergies in Europe
Schaffner, U., Steinbach, S., Sun, Y., Skjøth, C. A., de Weger, L. A., Lommen, S. T., Augustinus, B. A., Bonini, M., Karrer, G., Šikoparija, B., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15586-1 · Cited by 175
Metadata
- Authors
- Linneberg, A., Dam Petersen, K., Hahn-Pedersen, J., Hammerby, E., Serup-Hansen, N., & Boxall, N.
- Affiliations
- University of Copenhagen (DK)
- ALK-Abelló (Denmark) (DK)
- Corresponding author
- Linneberg, A.
- Venue
- Clinical and Molecular Allergy
- Published
- 2016-09-28
- Volume
- 14
- Issue
- 1
- Pages
- 12-12
- ISSN
- 1476-7961 (ISSN-L)
- PMC
- PMC5041537
- OpenAlex
- W2526022291
- Cited by
- 151
- References
- 90
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 14 · 2023: 8 · 2022: 16 · 2021: 26 · 2020: 16 · 2019: 16 · 2018: 17 · 2017: 14 · 2016: 2
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Clinical and Molecular Allergy (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion, cc-by)
- Funders
- ALK, Hørsholm, Denmark
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Indoor Air Quality and Microbial Exposure
- Keywords
- allergic rhinitis, allergic asthma, house dust mite allergy, health-related quality of life, economic burden, absenteeism, presenteeism, disease burden, SF-36, SF-12
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Burden of allergic respiratory disease: a systematic review. https://app.cochat.ai/papers/10.1186/s12948-016-0049-9
- The paper
- Linneberg, A., Dam Petersen, K., Hahn-Pedersen, J., Hammerby, E., Serup-Hansen, N., & Boxall, N. (2016). Burden of allergic respiratory disease: a systematic review. Clinical and Molecular Allergy. https://doi.org/10.1186/s12948-016-0049-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.